General MedicationsORALGeneric
RENORMAX
SPIRAPRIL HYDROCHLORIDE
Standard Dose
3MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview RENORMAX is listed in Drugs@FDA under application 020240 (NDA).
Marketing status: Discontinued Active ingredient SPIRAPRIL HYDROCHLORIDE Form and strength TABLET;ORAL - 3MG Sponsor SCHERING Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview RENORMAX is listed in Drugs@FDA under application 020240 (NDA). Marketing status: Discontinued Active ingredient SPIRAPRIL HYDROCHLORIDE Form and strength TABLET;ORAL - 3MG Sponsor SCHERING Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.